Finance

Beta
Lists
ALMR:NASDAQ
Alamar Biosciences Inc
$26.87
+12.76%
(+3.04) 1D
$26.70
-0.63% (-0.17)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALMR...
Open
$23.87
High
$27.42
Low
$23.36
Mkt. cap
1.86B
Avg. vol.
243.51K
Volume
513.79K
52-wk high
$27.42
52-wk low
$18.84
Shares outstanding
69.31M
No. of employees
222
Open
$23.87
High
$27.42
Low
$23.36
Mkt. cap
1.86B
Avg. vol.
243.51K
Volume
513.79K
52-wk high
$27.42
52-wk low
$18.84
Shares outstanding
69.31M
No. of employees
222
News stories
From sources across the web
About Alamar Biosciences Inc
CEO-
Employees222
Founded2018
Headquarters-
SectorHealth care
Websitealamarbio.com
Analyst ratings
Based on 5 analysts giving stock ratings to ALMR in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ALMR in the last 3 months.
Highest
Current $26.87
$35.00 (+30.26%)
Average
$30.00 (+11.65%)
Lowest
$27.00 (+0.48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$28.00
+4.2%
06/09/2026
Puneet Souda
Leerink Partners
Buy
Initiated
$35.00
+30.3%
05/12/2026
Michael Ryskin
Bank of America Securities
Hold
Initiated
$27.00
+0.5%
05/12/2026
Daniel Brennan
TD Cowen
Buy
Initiated
$30.00
+11.6%
05/12/2026
Casey Woodring
J.P. Morgan
Buy
Initiated
$30.00
+11.6%
05/12/2026
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.74 / -
0.00%miss
Revenue / Est. (USD)
26.04M / -
0.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
13.09M
26.04M
Cost of goods sold
6.70M
11.58M
Cost of revenue
6.70M
11.58M
Research and development expenses
8.30M
13.02M
Total research and development expenses
-
-
Selling, general, and admin expenses
6.64M
13.79M
Operating expense
14.94M
26.80M
Total operating expenses
21.64M
38.38M
Operating income
-8.55M
-12.35M
Other non operating income
-
-
EBT including unusual items
-7.66M
-20.86M
EBT excluding unusual items
-7.66M
-12.27M
Income tax expense
-
464.00K
Effective tax rate
-
-2.22%
Other operating expenses
-
-
Net income
-7.66M
-21.32M
Net profit margin
-58.51%
-81.91%
Earnings per share
-
-
Interest and investment income
786.00K
539.00K
Interest expense
-46.00K
-223.00K
Net interest expenses
740.00K
316.00K
Depreciation and amortization charges
-
-
EBITDA
-7.66M
-11.18M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of ALMR
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer